Desmoid Tumors Market Production, Value, Share and Development plans in future till 2023
Desmoid tumors are the benign fibrous growths which usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States.
Desmoid Tumors Market Is Expected to Grow at a CAGR 4.5% During
the Forecast Period Of 2017-2023”.
Avail a Free Sample Here: https://www.marketresearchfuture.com/sample_request/4859
Tumors associated with familial adenomatous polyposis (FAP) are
less common than sporadic desmoid tumors. On the molecular level, desmoid tumor
is characterized by one of the two mutations in the gene i.e. mutations in the
adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During
diagnostic procedures CTNNB1 mutation is detected, especially, when
pathological differential diagnosis is difficult.
The symptoms of desmoid tumors include a painless swelling or
lump, pain and obstruction of the bowels, limping, pain caused by compressed
nerves or muscles, and others. For the diagnosis of desmoid tumor there are
many non-invasive methods available to detect desmoid tumor which include ultrasound,
MRI scan, and CT scan. The actual diagnosis of this tumor can be made only
after examining a small piece of the tumor by a trained pathologist.
High cost of treatment & management of desmoid tumors and
related disorders, and lack of infrastructure in middle- and low-income
countries may hamper the growth of the market.
Competitive Analysis:
Some of key the players in the Desmoid Tumors Market are
- Amgen
Inc.
- Novartis
AG
- Abbott
Laboratories
- Bayer
AG
- AbbVie
Inc.
- Beckman
Coulter Inc.
- Stryker
Corporation
- Debiopharm
Group
- Hoffmann-La
Roche Ltd
- and
others.
Market Segmental Analysis:
The desmoid tumors market is segmented on the basis of diagnosis,
treatment, and end-user.
On the basis of diagnosis, market
is segmented into biopsy, electron microscopic examination, immunohistochemical
analysis, others
On the basis of treatment, market
is classified into surgery, radiation therapy, anti-inflammatory medication,
hormone therapy, chemotherapy, novel molecular-targeted therapy, others. Novel
molecular-targeted therapy is further segmented into gleevec based therapy, and
sorafenib based therapy
On the basis of end-user, market
is segmented into hospital, clinics, and others.
Brows Complete Detailed Premium Research Report at https://www.marketresearchfuture.com/reports/desmoid-tumors-market-4859
Desmoid Tumors Market Regional Analysis:
The Americas dominate the desmoid tumors market owing to the
rising awareness among people, and increasing healthcare expenditure. As per
the facts suggested by the Centers for Disease Control and Prevention (CDC), it
is found that out of total annual healthcare expenditure, 86% is for people
with chronic health conditions in the United States. Furthermore, increasing
participation of bigger players and new marketers towards advancement in
treatment approaches have also attracted a great deal of attention.
Europe holds the second position in the desmoid tumors market. It
is expected that the support provided by government bodies for research &
development and improvement in reimbursement policies in healthcare will drive
the market in Europe region.
Asia Pacific is the fastest growing desmoid tumors market owing to
the huge patient pool and developing healthcare technology.
The Middle East & Africa has the lowest market for desmoid
tumors market due to lack of technical knowledge and poor medical
facilities.
About Market Research Future: we
enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
In order to stay updated with technology and work process of the
industry, MRFR often plans & conducts meet with the industry experts and
industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment